Skip to content
Health
Link copied to clipboard
Link copied to clipboard

The FDA just approved the first gene-editing treatment, and CHOP played a key role

The CRISPR treatment enables people with sickle cell disease to make a normal form of hemoglobin. Other such treatments are being tested for cancer and heart disease.

CRISPR gene-editing is used to treat sickle-cell disease
CRISPR gene-editing is used to treat sickle-cell diseaseRead moreAnton Klusener/ Staff illustration/ Getty Images
    by Tom Avril
    Published